Key Statistics for BAYN
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (EUR) (ttm)
|Est. EPS (EUR) (12/2013)
|Est. PEG Ratio
|Market Cap (M EUR)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (EUR)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BAYN
- Net Income (M/EUR)
Bayer AG produces and markets healthcare and agricultural products, and polymers. The Company manufactures products that include aspirin, antibiotics, anti-infectives, and cardiovascular, oncology, and central nervous system drugs, over-the-counter medications, diagnostics, animal health products, crop protection products, plastics, and polyurethanes.
More Company Profile & Key Executives for BAYN
|Marijn E DekkersChairman-Mgmt Board/CEO||Werner BaumannCFO/Member-Mgmt Board|
|Wolfgang PlischkeCTO/Member-Mgmt Board||Richard PottChief Strategy & Human Resource|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries